Effects of Brinzolamide on Aqueous Humor Dynamics in Monkeys and Rabbits

Carol B Toris, Gui Lin Zhan, Marsha A. McLaughlin

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

This study examines the mechanisms by which brinzolamide reduces intraocular pressure (IOP) in healthy rabbits and in monkeys with unilateral ocular hypertension. Intraocular pressures were measured by pneumatonometry and aqueous flow was determined by fluorophotometry before and after three twice-daily drops of 1% brinzolamide to both eyes per monkey and after similar treatment to one eye per rabbit. In monkeys, outflow facility was determined by fluorophotometry and uveoscleral outflow was calculated. In rabbits, outflow facility was determined by two-level constant pressure infusion and uveoscleral outflow was measured by an intracameral tracer technique. Compared with contralateral vehicle-treated rabbit eyes, IOP was reduced in brinzolamide-treated eyes by 2.5 ± 1.9 mmHg (mean ± standard deviation; p = .006) at four hours after the second dose. Aqueous flow was reduced by 0.50 ± 0.65 μl/min (p = .02). This effect was found in rabbits previously treated with brinzolamide but not in naive rabbits. Treated hypertensive eyes of monkeys had a reduction in IOP of 7.3 ± 8.8 mmHg (p = 0.01) and aqueous flow of 0.69 ± 1.10 μL/min (p = 0.05) when compared with baseline. Brinzolamide did not affect outflow facility or uveoscleral outflow in either rabbits or monkeys. It is concluded that, in normotensive eyes of rabbits and hypertensive eyes of monkeys, brinzolamide reduces IOP by reducing aqueous flow and not by affecting aqueous humor drainage.

Original languageEnglish (US)
Pages (from-to)397-404
Number of pages8
JournalJournal of Ocular Pharmacology and Therapeutics
Volume19
Issue number5
DOIs
StatePublished - Jan 1 2003

Fingerprint

Aqueous Humor
Haplorhini
Rabbits
Intraocular Pressure
Fluorophotometry
Ocular Hypertension
brinzolamide
Drainage
Pressure

ASJC Scopus subject areas

  • Ophthalmology
  • Pharmacology
  • Pharmacology (medical)

Cite this

Effects of Brinzolamide on Aqueous Humor Dynamics in Monkeys and Rabbits. / Toris, Carol B; Zhan, Gui Lin; McLaughlin, Marsha A.

In: Journal of Ocular Pharmacology and Therapeutics, Vol. 19, No. 5, 01.01.2003, p. 397-404.

Research output: Contribution to journalArticle

@article{28f40dda73394afca74766e46338aa75,
title = "Effects of Brinzolamide on Aqueous Humor Dynamics in Monkeys and Rabbits",
abstract = "This study examines the mechanisms by which brinzolamide reduces intraocular pressure (IOP) in healthy rabbits and in monkeys with unilateral ocular hypertension. Intraocular pressures were measured by pneumatonometry and aqueous flow was determined by fluorophotometry before and after three twice-daily drops of 1{\%} brinzolamide to both eyes per monkey and after similar treatment to one eye per rabbit. In monkeys, outflow facility was determined by fluorophotometry and uveoscleral outflow was calculated. In rabbits, outflow facility was determined by two-level constant pressure infusion and uveoscleral outflow was measured by an intracameral tracer technique. Compared with contralateral vehicle-treated rabbit eyes, IOP was reduced in brinzolamide-treated eyes by 2.5 ± 1.9 mmHg (mean ± standard deviation; p = .006) at four hours after the second dose. Aqueous flow was reduced by 0.50 ± 0.65 μl/min (p = .02). This effect was found in rabbits previously treated with brinzolamide but not in naive rabbits. Treated hypertensive eyes of monkeys had a reduction in IOP of 7.3 ± 8.8 mmHg (p = 0.01) and aqueous flow of 0.69 ± 1.10 μL/min (p = 0.05) when compared with baseline. Brinzolamide did not affect outflow facility or uveoscleral outflow in either rabbits or monkeys. It is concluded that, in normotensive eyes of rabbits and hypertensive eyes of monkeys, brinzolamide reduces IOP by reducing aqueous flow and not by affecting aqueous humor drainage.",
author = "Toris, {Carol B} and Zhan, {Gui Lin} and McLaughlin, {Marsha A.}",
year = "2003",
month = "1",
day = "1",
doi = "10.1089/108076803322472962",
language = "English (US)",
volume = "19",
pages = "397--404",
journal = "Journal of Ocular Pharmacology and Therapeutics",
issn = "1080-7683",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Effects of Brinzolamide on Aqueous Humor Dynamics in Monkeys and Rabbits

AU - Toris, Carol B

AU - Zhan, Gui Lin

AU - McLaughlin, Marsha A.

PY - 2003/1/1

Y1 - 2003/1/1

N2 - This study examines the mechanisms by which brinzolamide reduces intraocular pressure (IOP) in healthy rabbits and in monkeys with unilateral ocular hypertension. Intraocular pressures were measured by pneumatonometry and aqueous flow was determined by fluorophotometry before and after three twice-daily drops of 1% brinzolamide to both eyes per monkey and after similar treatment to one eye per rabbit. In monkeys, outflow facility was determined by fluorophotometry and uveoscleral outflow was calculated. In rabbits, outflow facility was determined by two-level constant pressure infusion and uveoscleral outflow was measured by an intracameral tracer technique. Compared with contralateral vehicle-treated rabbit eyes, IOP was reduced in brinzolamide-treated eyes by 2.5 ± 1.9 mmHg (mean ± standard deviation; p = .006) at four hours after the second dose. Aqueous flow was reduced by 0.50 ± 0.65 μl/min (p = .02). This effect was found in rabbits previously treated with brinzolamide but not in naive rabbits. Treated hypertensive eyes of monkeys had a reduction in IOP of 7.3 ± 8.8 mmHg (p = 0.01) and aqueous flow of 0.69 ± 1.10 μL/min (p = 0.05) when compared with baseline. Brinzolamide did not affect outflow facility or uveoscleral outflow in either rabbits or monkeys. It is concluded that, in normotensive eyes of rabbits and hypertensive eyes of monkeys, brinzolamide reduces IOP by reducing aqueous flow and not by affecting aqueous humor drainage.

AB - This study examines the mechanisms by which brinzolamide reduces intraocular pressure (IOP) in healthy rabbits and in monkeys with unilateral ocular hypertension. Intraocular pressures were measured by pneumatonometry and aqueous flow was determined by fluorophotometry before and after three twice-daily drops of 1% brinzolamide to both eyes per monkey and after similar treatment to one eye per rabbit. In monkeys, outflow facility was determined by fluorophotometry and uveoscleral outflow was calculated. In rabbits, outflow facility was determined by two-level constant pressure infusion and uveoscleral outflow was measured by an intracameral tracer technique. Compared with contralateral vehicle-treated rabbit eyes, IOP was reduced in brinzolamide-treated eyes by 2.5 ± 1.9 mmHg (mean ± standard deviation; p = .006) at four hours after the second dose. Aqueous flow was reduced by 0.50 ± 0.65 μl/min (p = .02). This effect was found in rabbits previously treated with brinzolamide but not in naive rabbits. Treated hypertensive eyes of monkeys had a reduction in IOP of 7.3 ± 8.8 mmHg (p = 0.01) and aqueous flow of 0.69 ± 1.10 μL/min (p = 0.05) when compared with baseline. Brinzolamide did not affect outflow facility or uveoscleral outflow in either rabbits or monkeys. It is concluded that, in normotensive eyes of rabbits and hypertensive eyes of monkeys, brinzolamide reduces IOP by reducing aqueous flow and not by affecting aqueous humor drainage.

UR - http://www.scopus.com/inward/record.url?scp=0142244531&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142244531&partnerID=8YFLogxK

U2 - 10.1089/108076803322472962

DO - 10.1089/108076803322472962

M3 - Article

VL - 19

SP - 397

EP - 404

JO - Journal of Ocular Pharmacology and Therapeutics

JF - Journal of Ocular Pharmacology and Therapeutics

SN - 1080-7683

IS - 5

ER -